Useful resources |
Monoamine oxidase B inhibitors for early Parkinson's disease (Cochrane Review) ABSTRACT Background: It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD). Clinical trials have produced conflicting results. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |